May 28, 2025 9:00am EDT bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
May 20, 2025 9:00am EDT bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
